NeogenNEOG
About: Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
Employees: 1,315
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 52
0% more repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 116
0.74% less ownership
Funds ownership: 119.74% [Q4 2024] → 119.0% (-0.74%) [Q1 2025]
2% less funds holding
Funds holding: 341 [Q4 2024] → 335 (-6) [Q1 2025]
29% less capital invested
Capital invested by funds: $3.15B [Q4 2024] → $2.24B (-$912M) [Q1 2025]
74% less call options, than puts
Call options by funds: $544K | Put options by funds: $2.07M
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Piper Sandler David Westenberg | 10%downside $5 | Neutral Maintained | 22 Apr 2025 |
Guggenheim Subbu Nambi | 135%upside $13 | Buy Maintained | 10 Apr 2025 |
Financial journalist opinion
Based on 10 articles about NEOG published over the past 30 days









